TW201336861A - 雄甾－３β，５α，６β－三醇的晶型化合物及其製備方法 - Google Patents

雄甾－３β，５α，６β－三醇的晶型化合物及其製備方法 Download PDF

Info

Publication number
TW201336861A
TW201336861A TW102108093A TW102108093A TW201336861A TW 201336861 A TW201336861 A TW 201336861A TW 102108093 A TW102108093 A TW 102108093A TW 102108093 A TW102108093 A TW 102108093A TW 201336861 A TW201336861 A TW 201336861A
Authority
TW
Taiwan
Prior art keywords
solvent
triol
crystal
ethanol
androst
Prior art date
Application number
TW102108093A
Other languages
English (en)
Chinese (zh)
Inventor
Sui-Zhen Lin
jing-xia Zhang
Xin-Hua Li
Original Assignee
Guangzhou Cellprotek Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46557937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW201336861(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Guangzhou Cellprotek Pharmaceutical Ltd filed Critical Guangzhou Cellprotek Pharmaceutical Ltd
Publication of TW201336861A publication Critical patent/TW201336861A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0007—Androstane derivatives not substituted in position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
TW102108093A 2012-03-08 2013-03-07 雄甾－３β，５α，６β－三醇的晶型化合物及其製備方法 TW201336861A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210060611.6A CN102617685B (zh) 2012-03-08 2012-03-08 雄甾-3β,5α,6β-三醇的晶型化合物及其制备方法

Publications (1)

Publication Number Publication Date
TW201336861A true TW201336861A (zh) 2013-09-16

Family

ID=46557937

Family Applications (1)

Application Number Title Priority Date Filing Date
TW102108093A TW201336861A (zh) 2012-03-08 2013-03-07 雄甾－３β，５α，６β－三醇的晶型化合物及其製備方法

Country Status (13)

Country Link
US (3) US9688716B2 (enExample)
EP (2) EP2889303A4 (enExample)
JP (1) JP2015511587A (enExample)
KR (1) KR20150002653A (enExample)
CN (4) CN103626817B (enExample)
AU (1) AU2012372640B2 (enExample)
CA (2) CA2866398C (enExample)
IL (1) IL234492A (enExample)
IN (1) IN2014DN08198A (enExample)
RU (1) RU2608894C2 (enExample)
SG (1) SG11201405376TA (enExample)
TW (1) TW201336861A (enExample)
WO (1) WO2013131305A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015517418A (ja) 2012-05-07 2015-06-22 ザ プロクター アンド ギャンブルカンパニー 可撓性容器のための可撓性材料
CN109985048B (zh) * 2017-12-29 2021-06-29 广州市赛普特医药科技股份有限公司 2β,3α,5α-三羟基雄甾-6-酮用于炎症反应的治疗
US11532903B2 (en) * 2021-04-01 2022-12-20 Ideal Industries, Inc. Universal electrical connector

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2191576A (en) * 1936-11-21 1940-02-27 Soc Of Chemical Ind 3,5,6-trihydroxy androstane and pregnane compounds
US2191578A (en) 1939-07-24 1940-02-27 Crosley Corp Ice-cream tray
ATE15206T1 (de) * 1981-09-21 1985-09-15 Schering Ag 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-1 - one, ihre 3,15-trimethylessigsaeure-ester und ihre herstellung.
US6046185A (en) * 1996-07-11 2000-04-04 Inflazyme Pharmaceuticals Ltd. 6,7-oxygenated steroids and uses related thereto
CN101884638B (zh) 2010-07-09 2011-11-09 中山大学 5α-雄甾(烷)-3β,5,6β-三醇在制备神经元保护药物中的应用
CN101961311B (zh) 2010-09-21 2012-11-21 中山大学 一种5α-雄甾(烷)-3β,5,6β-三醇注射剂及其制备方法
CN102180928B (zh) * 2011-03-15 2013-01-16 广州市赛普特医药科技有限公司 3β,5α,6β-三羟基甾体化合物及其合成方法和应用

Also Published As

Publication number Publication date
EP3112374A1 (en) 2017-01-04
US9688716B2 (en) 2017-06-27
CN102617685B (zh) 2014-01-22
CA2866398A1 (en) 2013-09-12
EP2889303A1 (en) 2015-07-01
RU2014136891A (ru) 2016-05-10
AU2012372640A1 (en) 2014-09-25
US20150045566A1 (en) 2015-02-12
RU2608894C2 (ru) 2017-01-26
IN2014DN08198A (enExample) 2015-05-01
US9944672B2 (en) 2018-04-17
US20170305958A1 (en) 2017-10-26
CA2909998A1 (en) 2013-09-12
CN103626818B (zh) 2016-03-30
KR20150002653A (ko) 2015-01-07
CA2866398C (en) 2016-06-28
JP2015511587A (ja) 2015-04-20
US20170305957A1 (en) 2017-10-26
CN103626819B (zh) 2016-01-20
CN103626817A (zh) 2014-03-12
WO2013131305A1 (zh) 2013-09-12
CN103626817B (zh) 2016-01-20
CN102617685A (zh) 2012-08-01
AU2012372640B2 (en) 2015-07-09
SG11201405376TA (en) 2014-11-27
IL234492A (en) 2017-02-28
CN103626818A (zh) 2014-03-12
US9944673B2 (en) 2018-04-17
EP2889303A4 (en) 2016-02-17
CN103626819A (zh) 2014-03-12

Similar Documents

Publication Publication Date Title
WO2021031102A1 (zh) Daprodustat的晶型及其制备方法和用途
TW201336861A (zh) 雄甾－３β，５α，６β－三醇的晶型化合物及其製備方法
CN102746275B (zh) 结晶型艾普拉唑钠及其制备方法
CN102746276B (zh) 一种艾普拉唑钠晶型及其制备方法
CN109810095A (zh) 一种盐酸羟哌吡酮新晶型及其制备方法
CN102087233A (zh) 一种表征化学反应进行程度及转化率的方法
CN105315278A (zh) 吡咯喹啉醌a晶型及其制备方法
CN106749191A (zh) 艾普拉唑晶型ⅱ及其制备方法
US9475794B2 (en) Process for the preparation of polymorphs of imidacloprid
WO2015113370A1 (zh) 一种甜菊糖a苷晶体及其制备方法和用途
US10562895B2 (en) Pyrroloquinoline quinone B crystal form and preparation method therefor
CN104250227A (zh) 瑞戈非尼新晶型及其制备方法
CN102746277A (zh) 一种结晶形式的艾普拉唑钠及其制备方法
JP2017523210A (ja) ６−アリールアミノピリドンカルボキサミド化合物の結晶、およびその製造方法
Murphy et al. Thermodynamic stability considerations for isostructural dehydrates
Fujii et al. Metastable polymorphic form of isopropylbenzophenone derivative directly obtained by the solid-state photoreaction investigated by ab initio powder X-ray diffraction analysis
CN106588886A (zh) 艾普拉唑晶型ⅲ及其制备方法
CN110964017A (zh) 瑞博西尼单琥珀酸盐的多晶型物及其制备方法和用途
Stieger et al. Crystal form conversion of nevirapine solvates subjected to elevated temperature and humidity: a qualitative study
CN116283782A (zh) 一种克霉唑的晶型及其制备方法和应用
CN118852150A (zh) 马来酸麦角乙脲的晶型i及其制备方法和应用
CN117003689A (zh) 一种碘解磷定的晶型及其制备方法
Kohli et al. Crystal Structure of 4, 4-Dimethyl-1-[2-phenyl-1-(phenylamino) ethyl]-piperidin-2, 6-dione
WO2021016929A1 (zh) 恶拉戈利与乙胺嘧啶的共晶型a及其制备方法和用途
JP2022547785A (ja) さまざまな形態の６－クロロ－２－エチル－Ｎ－（４－（４－（４－（トリフルオロメトキシ）フェニル）ピペリジン－１－イル）ベンジル）イミダゾ［１，２－ａ］ピリジン－３－カルボキサミド